EDWARD LIN: Open Payments
NPI 1881122315 · HACIENDA HEIGHTS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$391 in 15 payments from 8 companies in 2025. Trend: 2023 $202 · 2024 $380 · 2025 $391
Food & beverage: $391
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $119 |
| Alkermes, Inc. | 1 | $115 |
| Exact Sciences Corporation | 3 | $60 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Amgen Inc. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
Products named: VIVITROL, FARXIGA, Cologuard Collection Kit, BREZTRI, ZENPEP, GEMTESA, EVENITY, ZORYVE.
Industry payments across CA — which companies pay providers there.
